[RENAPE network: Towards more equitable access to care and expertise for patients with rare peritoneal cancers]

Ann Pathol. 2024 Jul;44(4):291-295. doi: 10.1016/j.annpat.2024.05.003. Epub 2024 Jun 4.
[Article in French]

Abstract

Since its creation in 2010, the progressive structuration of the RENAPE network (Réseau national de prise en charge des tumeurs rares du péritoine) supported by the "Institut national du cancer" and the "Direction générale de l'offre de soins", allowed the optimization of the healthcare system involved in the management of the rare cancers of the peritoneum. In this setting, the RENA-PATH group has also been reinforced, notably by its recognized diagnostic expertise in pathology and its interface with the MESOPATH group. Moreover RENAPE and RENA-PATH led to guidelines diffusion through the integration, in 2019, to the ``Thesaurus National de Cancérologie Digestive'' (TNCD) and to post-university medical education programs. The aim of this article is to highlight the missions of the RENAPE and RENA-PATH, notably the equity in terms of expertise, access to the networks and their improvement in the management of peritoneal diseases.

Keywords: Cancer rare; Network; Peritoneum; Péritoine; RENA-PATH; RENAPE; Rare cancer; Réseau.

Publication types

  • English Abstract

MeSH terms

  • France
  • Health Services Accessibility*
  • Humans
  • Peritoneal Neoplasms* / pathology
  • Peritoneal Neoplasms* / therapy
  • Rare Diseases* / therapy